Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2020-05-29 | 2020-07-23 | 116162 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2024-03-28 | 2024-04-25 | 223844 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2021-01-07 | 2021-03-04 | 131081 |
| TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2021-01-15 | 2021-02-25 | 131703 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2021-01-15 | 2021-02-25 | 131706 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2021-03-04 | 2021-03-11 | 135117 |
| TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2021-08-05 | 2021-09-09 | 143719 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2022-03-24 | 2022-04-09 | 157271 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183389 |
| TEVA-OLANZAPINE | 20MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183410 |
| TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190695 |
| TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-06-08 | 2023-07-21 | 194109 |
| TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-06-16 | 2023-07-05 | 195216 |
| TEVA-OLANZAPINE | 10MG | TABLET | Actual shortage | 2025-02-13 | 2025-04-04 | 250390 |
| TEVA-OLANZAPINE | 2.5MG | TABLET | Resolved | 2025-04-10 | 2025-05-08 | 254789 |
| TEVA-OLANZAPINE | 7.5MG | TABLET | Actual shortage | 2025-05-02 | 2025-05-08 | 256453 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-04-28 | 2022-12-22 | 159593 |
| TEVA-OLANZAPINE | 7.5MG | TABLET | Resolved | 2022-05-19 | 2022-08-19 | 161000 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161952 |
| TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2022-06-03 | 2022-08-09 | 161955 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |